Viracta Therapeutics
Price & Volume
Stats
See more52W Range | $0.13-$1.31 |
Market Cap | $6M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.10 |
News
See moreYahoo Finance • last year
Viracta Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Yahoo Finance • last year
Viracta Therapeutics to Present at Upcoming Investor Conferences
Yahoo Finance • last year
Viracta Therapeutics to Host R&D Day Highlighting Nana-val in Epstein-Barr Virus (EBV)-Associated Cancers
Yahoo Finance • last year
Viracta Therapeutics to Host R&D Day on October 4, 2023
About
CEO | Mr. Mark Andrew Rothera |
Address | 2533 South Coast Highway 101, Cardiff, CA, United States, 92007 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 40 |
